HOXA9 anticorps (N-Term)
Aperçu rapide pour HOXA9 anticorps (N-Term) (ABIN6252036)
Antigène
Voir toutes HOXA9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Protein A Affinity Chromatography
-
Immunogène
- A recombinant protein fragment from the N-terminal region of human HOXA9 was used as the immunogen for this antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Western blot: 2-5 μg/mL
Provided assay concentrations are suggestions only, HOXA9 antibody titration may be required for optimal results. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- HOXA9 (Homeobox A9 (HOXA9))
-
Autre désignation
- HOXA9
-
Sujet
- HOXA9 is part of the A cluster of the homeobox family of DNA-binding transcription factors. This protein may play a role in gene expression, morphogenesis, and embryonic development. It and the fusion oncogene NUP98-HOXA9 have been implicated in leukemia. SMAD4 has been shown to negatively regulate HOXA9-mediated leukemia stem cell growth.
-
ID gène
- 3205
-
UniProt
- P31269
Antigène
-